Skip to content

US · HCTI · MEDICAL - HEALTHCARE INFORMATION SERVICES

Healthcare Triangle, Inc. (HCTI) intrinsic value and stock valuation

$2.88as of 2026-11-21 · Mkt cap 1.25M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Healthcare Triangle, Inc. DCF and intrinsic value

InvestorsCraft values HCTI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from HCTI’s statements →

Healthcare Triangle, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Pleasanton, CA 94588 healthcaretriangle.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$13.9M-15% 5y CAGRd
20192025
Net income
-$-9.48M
20192025
Free cash flow
-$-16.52M
20192025
Total equity
$9.94M+18.1% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$13.9M$11.7M$33.2M$45.9M$35.3M
Operating income-$-9.79M-$-4.75M-$-7.7M-$-16.32M-$-5.36M
Net income-$-9.48M-$-5.97M-$-8.69M-$-14.36M-$-5.95M
Operating cash flow-$-16.52M-$-1.08M-$-2.15M-$-5.35M-$-7.11M
Capital expenditure-$-10K$0.00-$-10K-$-1.13M-$-3.13M
Free cash flow-$-16.52M-$-1.08M-$-2.16M-$-6.49M-$-10.24M
Total assets$22.7M$1.96M$6.86M$13.3M$24.6M
Total debt$10.7M$2.65M$3.88M$2.69M$3.45M
Net debt$3.11M$2.63M$2.65M$1.34M$1.68M
Total equity$9.94M-$-5.11M-$-1.39M$6.04M$16.1M
Cash and short-term investments$7.62M$20K$1.23M$1.34M$1.77M
Income statement
20252024202320222021
Revenue$13.9M$11.7M$33.2M$45.9M$35.3M
Cost of revenue$12M$8.81M$26.4M$34.6M$24.8M
Gross profit$1.89M$2.89M$6.78M$11.3M$10.5M
Research and development expenses$540K$430K$800K$8.14M$5.26M
Selling, general and administrative expenses$10.4M$6.15M$10.4M$12.2M$9.2M
Other expenses$720K$1.06M$3.28M$7.31M$1.42M
Operating expenses$11.7M$7.64M$14.5M$27.6M$15.9M
Cost and expenses$23.7M$16.5M$40.9M$62.2M$40.6M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$570K$1.21M$970K$210K$570K
Depreciation and amortization$700K$890K$1.57M$2.94M$1.42M
Ebitda-$-8.2M-$-3.85M-$-6.12M-$-10.7M-$-3.94M
Operating income-$-9.79M-$-4.75M-$-7.7M-$-16.32M-$-5.36M
Total other income/expenses, net$310K-$-1.21M-$-960K$2.47M-$-570K
Income before tax-$-9.48M-$-5.96M-$-8.65M-$-13.85M-$-5.92M
Income tax expense$0.00$10K$40K$510K$20K
Net income-$-9.48M-$-5.97M-$-8.69M-$-14.36M-$-5.95M
Weighted average shares outstanding$0.00$0.00$0.00$0.00$0.00
Weighted average diluted shares outstanding$0.00$0.00$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$7.62M$20K$1.23M$1.34M$1.77M
Net receivables$2.07M$1.11M$3.6M$5.87M$9.67M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$13.2M$1.45M$5.65M$8.02M$11.8M
Property, plant and equipment, net$10K$10K$40K$80K$250K
Goodwill and intangible assets$5.75M$0.00$860K$4.08M$11.8M
Long-term investments$0.00$500K$300K$1.07M$0.00
Total non-current assets$9.59M$510K$1.21M$5.24M$12.8M
Total assets$22.7M$1.96M$6.86M$13.3M$24.6M
Accounts payable$740K$2.54M$1.95M$1.48M$1.87M
Short-term debt$10.7M$2.65M$3.79M$2.69M$3.45M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$12.8M$7.08M$8.15M$6.6M$6.25M
Long-term debt$0.00$0.00$100K$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$0.00$100K$620K$2.23M
Capital lease obligations$0.00$0.00$0.00$0.00$180K
Total liabilities$12.8M$7.08M$8.25M$7.22M$8.48M
Common stock$10K$0.00$0.00$0.00$0.00
Retained earnings-$-43M-$-33.57M-$-27.6M-$-18.92M-$-2.66M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$9.94M-$-5.11M-$-1.39M$6.04M$16.1M
Total investments$0.00$500K$300K$1.07M$0.00
Total debt$10.7M$2.65M$3.88M$2.69M$3.45M
Net debt$3.11M$2.63M$2.65M$1.34M$1.68M
Cash flow statement
20252024202320222021
Net income-$-9.48M-$-5.97M-$-8.69M-$-14.36M-$-5.95M
Depreciation and amortization$700K$890K$1.57M$2.94M$1.42M
Stock-based compensation$450K$90K$170K$260K$50K
Change in working capital-$-8.69M$2.69M$3M$3.75M-$-3.95M
Accounts receivable-$-910K$2.12M$3.04M$3.33M-$-3.65M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-1.49M$0.00$0.00$0.00$0.00
Net cash provided by operating activities-$-16.52M-$-1.08M-$-2.15M-$-5.35M-$-7.11M
Investments in property, plant and equipment$0.00$0.00-$-10K-$-1.13M-$-3.13M
Acquisitions, net$0.00$0.00$0.00$0.00-$-4.5M
Net cash used for investing activities-$-1.75M$0.00-$-10K-$-1.13M-$-7.63M
Common stock issued$17M$0.00$500K$5.89M$14.2M
Common stock repurchased$0.00$0.00$0.00-$-140K$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$25.9M-$-130K$2.06M$6.06M$15.1M
Net change in cash$7.61M-$-1.21M-$-110K-$-430K$370K
Cash at end of period$7.62M$20K$1.23M$1.34M$1.77M
Operating cash flow-$-16.52M-$-1.08M-$-2.15M-$-5.35M-$-7.11M
Capital expenditure-$-10K$0.00-$-10K-$-1.13M-$-3.13M
Free cash flow-$-16.52M-$-1.08M-$-2.16M-$-6.49M-$-10.24M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Healthcare Triangle, Inc.

        Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.

        CEO
        Lakshmanan Kannappan
        Employees
        84
        Beta
        1.09

        Explore

        Frequently asked questions

        What is the intrinsic value of Healthcare Triangle, Inc. (HCTI)?

        InvestorsCraft does not currently publish an intrinsic value for HCTI. How the IC value is calculated.

        Is HCTI undervalued?

        InvestorsCraft does not publish an undervaluation signal for HCTI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.